z-logo
Premium
The therapeutic benefits of heme oxygenase (HO‐1) inhibition in the management of systemic malignancies besides hepatocellular carcinomas
Author(s) -
Kapoor Shailendra
Publication year - 2009
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.24337
Subject(s) - growth inhibition , cancer research , protoporphyrin ix , heme oxygenase , melanoma , zinc protoporphyrin , medicine , heme , cell culture , cell growth , pharmacology , chemistry , photodynamic therapy , biology , enzyme , biochemistry , organic chemistry , genetics

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom